Gene Therapy
Key Statistics
bluebird bio
PM Group Office
53,000 sq.ft.

bluebird bio is a clinical-stage company that develops potentially transformative therapies with product platforms including gene therapy, cancer immunotherapy and gene editing. PM Group has worked with bluebird bio since 2015, providing high level Subject Matter Expert (SME) support, as well as engineering design services.

Do you have a pharmaceutical project? Talk to one of our experts.

Andy Rayner
Andy Rayner

Pharmaceutical Sector Director

Viral vector manufacturing facility

PM Group designed a 53,000 sq.ft. world-class viral vector manufacturing facility in Durham, NC. The project had a fast track schedule with 16 months from construction commencement to manufacturing start. Our team provided process engineering design including P&IDs, equipment specification, procurement support, process simulation and modeling for production planning.


Technologies on this Project include: 

  • Single use technologies (bioreactors and purification) for viral vector preparation 
  • Filling line and isolator 
  • BSL-2 level of containment 
Andy Rayner

Pharmaceutical Sector Director